Concomitant loss of dynorphin, NARP, and orexin in narcolepsy

被引:247
作者
Crocker, A
España, RA
Papadopoulou, M
Saper, CB
Faraco, J
Sakurai, T
Honda, M
Mignot, E
Scammell, TE
机构
[1] Harvard Inst Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
[2] Harvard Inst Med, Dept Neurol, Boston, MA 02115 USA
[3] Stanford Univ, Ctr Narcolepsy, Dept Psychiat, Palo Alto, CA 94304 USA
[4] Univ Tsukuba, Dept Pharmacol, Tsukuba, Ibaraki 305, Japan
[5] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 305, Japan
关键词
D O I
10.1212/01.WNL.0000168173.71940.ab
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Narcolepsy with cataplexy is associated with a loss of orexin/hypocretin. It is speculated that an autoimmune process kills the orexin-producing neurons, but these cells may survive yet fail to produce orexin. Objective: To examine whether other markers of the orexin neurons are lost in narcolepsy with cataplexy. Methods: We used immunohistochemistry and in situ hybridization to examine the expression of orexin, neuronal activity-regulated pentraxin (NARP), and prodynorphin in hypothalami from five control and two narcoleptic individuals. Results: In the control hypothalami, at least 80% of the orexin-producing neurons also contained prodynorphin mRNA and NARP. In the patients with narcolepsy, the number of cells producing these markers was reduced to about 5 to 10% of normal. Conclusions: Narcolepsy with cataplexy is likely caused by a loss of the orexin-producing neurons. In addition, loss of dynorphin and neuronal activity-regulated pentraxin may contribute to the symptoms of narcolepsy.
引用
收藏
页码:1184 / 1188
页数:5
相关论文
共 27 条
[1]
Cocaine and methamphetamine differentially affect opioid peptide mRNA expression in the striatum [J].
Adams, DH ;
Hanson, GR ;
Keefe, KA .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (05) :2061-2070
[2]
Benbadis SR, 1996, PHARMACOTHERAPY, V16, P463
[3]
The genetics of narcolepsy [J].
Chabas, D ;
Taheri, S ;
Renier, C ;
Mignot, E .
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2003, 4 :459-483
[4]
Narcolepsy in orexin knockout mice:: Molecular genetics of sleep regulation [J].
Chemelli, RM ;
Willie, JT ;
Sinton, CM ;
Elmquist, JK ;
Scammell, T ;
Lee, C ;
Richardson, JA ;
Williams, SC ;
Xiong, YM ;
Kisanuki, Y ;
Fitch, TE ;
Nakazato, M ;
Hammer, RE ;
Saper, CB ;
Yanagisawa, M .
CELL, 1999, 98 (04) :437-451
[5]
Orexin (hypocretin) neurons contain dynorphin [J].
Chou, TC ;
Lee, CE ;
Lu, J ;
Elmquist, JK ;
Hara, J ;
Willie, JT ;
Beuckmann, CT ;
Chemelli, RM ;
Sakurai, T ;
Yanagisawa, M ;
Saper, CB ;
Scammell, TE .
JOURNAL OF NEUROSCIENCE, 2001, 21 (19)
[6]
Increased prevalence of obesity in narcoleptic patients and relatives [J].
Dahmen, N ;
Bierbrauer, J ;
Kasten, M .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2001, 251 (02) :85-89
[7]
Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO
[8]
2-R
[9]
Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to tuberomammillary neurons [J].
Eriksson, KS ;
Sergeeva, OA ;
Selbach, O ;
Haas, HL .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 19 (05) :1278-1284
[10]
TREATMENT OF NARCOLEPSY WITH CODEINE [J].
FRY, JM ;
PRESSMAN, MR ;
DIPHILLIPO, MA ;
FORSTPAULUS, M .
SLEEP, 1986, 9 (01) :269-274